Amidst outcry over dangerous products . . .

Aides: Senate Cosmetics Bill Likely to Move Forward, House Bill Stalled

August 17, 2016 at 6:36 PM
A Senate bill intended to grant FDA greater regulatory power over the cosmetic industry is likely to see movement before the end of the year, congressional aides told Inside Health Policy . But a competing House bill is unlikely to move forward. Sens. Dianne Feinstein (D-CA) and Susan Collins (R-ME) received positive feedback from the Senate health committee on their bill, the Personal Care Products Safety Act, and hope for a hearing in September, a Feinstein aide told Inside Health...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.